Randomized double-blind placebo-controlled trial of powdered brassica rapa ethanol extract on alteration of body composition and plasma lipid and adipocytokine profiles in overweight subjects

Journal of Medicinal Food

Volumn 16, Issue 2, 2013, Pages 133-138

  Jeon, Seon Min ^a   Kim, Ji Eun ^a   Shin, Su Kyung ^a   Kwon, Eun Young ^a   Jung, Un Ju ^a   Baek, Nam In ^b   Lee, Kyung Tae ^b   Jeong, Tae Sook ^c   Chung, Hae Gon ^d   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d GangHwa Agricultural R and D Center   (South Korea)

Author keywords

body composition; humans; lipids

Indexed keywords

ADIPOCYTOKINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BRASSICA RAPA EXTRACT; CHOLESTEROL; COMPLEMENT FACTOR D; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY COMPOSITION; BODY MASS; BRASSICA RAPA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIVER TOXICITY; MALE; NUTRITION; OBESITY; PLANT ROOT; POWDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; WEIGHT REDUCTION;

ADIPOKINES; ADULT; BODY COMPOSITION; BRASSICA RAPA; FEMALE; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; OVERWEIGHT; PLANT EXTRACTS; YOUNG ADULT;

EID: 84873615386     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2012.2249     Document Type: Article

References (26)

1. World Health Organization, International Association for the Study of Obesity, International Obesity Task Force: The Asia-Pacific Perspective: redefining obesity and its treatment. Sydney: Health Communications, 2000;1-284.
2. Bosello O, Armellini F, Zamboni M, et al.: The benefits of modest weight loss in type II diabetes. Int J Obes 1997;21(Suppl 1): S10-S13. (Pubitemid 27160692)
3. Van Gaal LF, Wauters MA, De Leeuw IH: The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes 1997;21(Suppl 1):S5-S9. (Pubitemid 27160691)
4. Popkin BM, Doak CM: The obesity epidemic is a worldwide phenomenon. Nutr Rev 1998;56:106-114. (Pubitemid 28209802)
5. Kristal AR: Brassica vegetables and prostate cancer risk: a review of the epidemiologic evidence. Pharm Biol 2002;40:55-58. (Pubitemid 34497351)
6. van Poppel G, Verhoeven DT, Verhagen H, et al.: Brassica vegetables and cancer prevention. Epidemiology and mechanisms. Adv Exp Med Biol 1999;472:159-168.
7. Kim YH, Kim YW, Oh YJ, et al.: Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced neph-rotoxicity in LLC-PK1 cells and rats. Biol Pharm Bull 2006;29:2436-2441.
8. Jung UJ, Baek NI, Chung HG, et al.: Effects of the ethanol extract of the roots of Brassica rapa on glucose and lipid metabolism in C57BL/KsJ-db/db mice. Clin Nutr 2008;27:158-167. (Pubitemid 351216895)
9. Shin JS, Noh YS, Lee Y, et al.: Arvelexin isolated from the Brassica rapa abolishes inducible NF-kB activation by inhibiting IKK activation, thereby suppressing NF-kB-regulated pro-inflammatory gene expression. Br J Pharmacol 2011;164:145-158.
10. Food and Agriculture Organization of the United Nations: Food-based dietary guidelines. www.fao.org/es/esn/fbdg (accessed January 1999).
11. Lim S, Shin H, Song JH, et al.: Increasing prevalence of metabolic syndrome in Korea: The Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34:1323-1328.
12. Castelli WP: Lipids, risk factors and ischaemic heart disease. Atherosclerosis 1996;124(Suppl):S1-S9.
13. Linn S, Fulwood R, Carroll M, et al.: Serum total cholesterol: HDL cholesterol ratios in US white and black adults by selected demographic and socioeconomic variables (HANES II). Am J Public Health 1991;81:1038-1043.
14. Castelli WP, Abbott RD, McNamara PM: Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983;67:730-734. (Pubitemid 13161449)
15. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
16. Jouven X, Desnos M, Guerot C, et al.: Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999;99:1978-1983. (Pubitemid 29183894)
17. Pilz S, Scharnagl H, Tiran B, et al.: Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 2006;91:2542-2547. (Pubitemid 44024615)
18. Wang CC, Goalstone ML, Draznin B: Molecular mechanisms of insulin resistance that impact cardiovascular biology. Diabetes 2004;53:2735-2740. (Pubitemid 39425897)
19. Xu H, Barnes GT, Yang Q, et al.: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830. (Pubitemid 38063705)
20. Otero M, Lago R, Gómez R, et al.: Leptin: a metabolic hormone that functions like a proinflammatory adipokine. Drug News Perspect 2006;19:21-26.
21. Cottam DR, Mattar SG, Barinas-Mitchell E, et al.: The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: Implications and effects of weight loss. Obes Surg 2004;14:589-600. (Pubitemid 38716577)
22. Caro JF, Kolaczynski JW, Nyce MR, et al.: Decreased cerebro-spinal-fluid/ serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 1996;348:159-161. (Pubitemid 26238099)
23. Yamauchi T, Hara K, Kubota N, et al.: Dual roles of adiponectin/acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine. Curr Drug Targets Immune Endocr Metabol Disord 2003;3:243-254.
24. Shimabukuro M, Higa N, Asahi T, et al.: Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J Clin En-docrinol Metab 2003;88:3236-3240. (Pubitemid 36877499)
25. Napolitano A, Lowell BB, Damm D, et al.: Concentrations of adipsin in blood and rates of adipsin secretion by adipose tissue in humans with normal, elevated and diminished adipose tissue mass. Int J Obes Relat Metab Disord 1994;18:213-218. (Pubitemid 24123456)
26. Schuppan D, Gorrell MD, Klein T, et al.: The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis. Liver Int 2010;30:795-808.